- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 251, Issue -, Pages 108545
Publisher
Elsevier BV
Online
2023-10-21
DOI
10.1016/j.pharmthera.2023.108545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis
- (2023) Emilia Neuwirt et al. Science Signaling
- IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model
- (2023) Elena Nasiri et al. Cells
- Coenzyme Q0 defeats NLRP3-mediated inflammation, EMT/metastasis, and Warburg effects by inhibiting HIF-1α expression in human triple-negative breast cancer cells
- (2023) Hsin-Ling Yang et al. ARCHIVES OF TOXICOLOGY
- Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity
- (2023) Saikat Manna et al. BIOMATERIALS
- NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
- (2023) Hampartsoum B. Barsoumian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lung adenocarcinoma promotion by air pollutants
- (2023) William Hill et al. NATURE
- IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model
- (2023) Veronika Lutz et al. Cancer Immunology Research
- IL18 at the Crossroads between Chronic Inflammation and T-cell Exhaustion in Pancreatic Cancer
- (2023) Ingunn M. Stromnes Cancer Immunology Research
- IL12/18/21 Preactivation Enhances the Antitumor Efficacy of Expanded γδT Cells and Overcomes Resistance to Anti–PD-L1 Treatment
- (2023) Huey Yee Teo et al. Cancer Immunology Research
- Imatinib-induced hepatotoxicity via oxidative stress and activation of NLRP3 inflammasome: an in vitro and in vivo study
- (2022) Feng-Ru Huang et al. ARCHIVES OF TOXICOLOGY
- NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
- (2022) Yue Ding et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
- (2022) Siri Tahtinen et al. NATURE IMMUNOLOGY
- The Impact of Ambient Environmental and Occupational Pollution on Respiratory Diseases
- (2022) Chinatsu Nishida et al. International Journal of Environmental Research and Public Health
- NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma
- (2022) Haitao Gu et al. Translational Lung Cancer Research
- Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
- (2022) Isak W. Tengesdal et al. Pharmaceuticals
- Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
- (2022) Mark P. Lythgoe et al. BRITISH JOURNAL OF CANCER
- Prognostic association between NLRP3 inflammasome expression level and operable pancreatic adenocarcinoma
- (2022) Lina Zheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- NLRP3-mediated Inflammation in CardioOncology: Sterile yet Harmful
- (2022) Adolfo G Mauro et al. Translational Research
- Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes
- (2022) Amy F. McLemore et al. JCI Insight
- Clonal Hematopoiesis and Risk of Incident Lung Cancer
- (2022) Ruiyi Tian et al. JOURNAL OF CLINICAL ONCOLOGY
- Common and rare variant associations with clonal haematopoiesis phenotypes
- (2022) Michael D. Kessler et al. NATURE
- Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
- (2022) Assunta Cirella et al. Cancer Immunology Research
- Insights into clonal hematopoiesis and its relation to cancer risk
- (2021) Shaneice R Mitchell et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
- (2021) Laetitia Douguet et al. Nature Communications
- Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells
- (2021) Lukas Hatscher et al. Science Signaling
- Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer
- (2021) Xuesong Wu et al. Cancer & Metabolism
- Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity
- (2021) Marilena Pariano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review
- (2021) Elena Ferrari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting tumor-stromal IL-6/STAT3 signaling through IL-1 receptor inhibition in pancreatic cancer
- (2021) Austin R Dosch et al. MOLECULAR CANCER THERAPEUTICS
- NLRP3 inflammasomes that induce antitumor immunity
- (2021) Dania Zhivaki et al. TRENDS IN IMMUNOLOGY
- Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
- (2021) Isak W. Tengesdal et al. Frontiers in Immunology
- H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion
- (2021) XiaoYi Zhang et al. INFLAMMATION RESEARCH
- NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression
- (2021) Sarah Adriana Scuderi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Associations between inflammasome‐related gene NLRP3 Polymorphisms (rs10754558 and rs35829419) and risk of bladder cancer in a Chinese population
- (2021) Gang Xu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
- (2021) Hanlin Yin et al. Cell Death & Disease
- Double-edged sword of inflammasome genetics in colorectal cancer prognosis
- (2020) Raylane Adrielle Gonçalves Cambui et al. CLINICAL IMMUNOLOGY
- A promiscuous inflammasome sparks replication of a common tumor virus
- (2020) Eric M. Burton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of HIF-1α in regulating NLRP3 inflammasome activation in bladder cancer.
- (2020) Yuan-Ru Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
- (2020) Shaima’a Hamarsheh et al. Nature Communications
- Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma
- (2020) Chi-Jung Chung et al. Scientific Reports
- NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
- (2020) Qiao Zheng et al. BIOSCIENCE REPORTS
- The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)
- (2020) Rosamaria Lappano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis
- (2020) Kelly L. Bolton et al. NATURE GENETICS
- Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
- (2020) Hailiang Liu et al. Frontiers in Oncology
- NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
- (2020) Fei Lu et al. CANCER LETTERS
- Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway
- (2020) Wei Chen et al. OncoTargets and Therapy
- Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment
- (2020) Futa Mimoto et al. Cell Reports
- NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma
- (2020) Zili Zhai et al. Pharmaceuticals
- Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer
- (2019) Oscar Calvillo-Argüelles et al. JAMA Cardiology
- Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab in High-risk Smoldering Multiple Myeloma
- (2019) Timothy A Brighton et al. CLINICAL CANCER RESEARCH
- Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM
- (2019) Michael Carty et al. IMMUNITY
- The NLRP3 inflammasome as pharmacological target
- (2019) Carlo Marchetti JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells
- (2019) Qing Wei et al. ONCOLOGY RESEARCH
- Factors Influencing Imatinib-Induced Hepatotoxicity
- (2019) Ji Min Han et al. Cancer Research and Treatment
- The role of NLRP3 inflammasome activation in radiation damage
- (2019) Jinlong Wei et al. BIOMEDICINE & PHARMACOTHERAPY
- Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion
- (2019) Lingling Si et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation
- (2019) Marco Di Gioia et al. NATURE IMMUNOLOGY
- NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis
- (2019) Nour Ershaid et al. Nature Communications
- NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
- (2018) Han Wang et al. BMC CANCER
- IL-1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer
- (2018) Te-Chia Wu et al. CANCER RESEARCH
- Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study
- (2018) Anna Francis et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Role of PD-1 during effector CD8 T cell differentiation
- (2018) Eunseon Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Interleukin-1 Signature in Breast Cancer Treated with Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors
- (2018) Charles Anthony Dinarello CANCER RESEARCH
- LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation
- (2018) Hui Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway
- (2018) Tianming Qiu et al. Cell Death & Disease
- Interleukin-18: Biological properties and role in disease pathogenesis
- (2017) Gilles Kaplanski IMMUNOLOGICAL REVIEWS
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
- (2017) Xiaodong Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
- (2017) Donnele Daley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D
- (2017) Kimberley D. Gutierrez et al. JOURNAL OF IMMUNOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer
- (2017) Ju Young Bae et al. Oncotarget
- NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma
- (2017) Xia Zhao et al. Oncotarget
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma
- (2016) John A. Lust et al. AMERICAN JOURNAL OF HEMATOLOGY
- Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes
- (2016) Tatsuya Hasegawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
- (2016) Gilbert G. G. Donders et al. DIAGNOSTIC CYTOPATHOLOGY
- Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes toBCR-ABLmutation-independent imatinib resistance
- (2016) Cho-Rong Lee et al. FEBS LETTERS
- Human Monocytes Engage an Alternative Inflammasome Pathway
- (2016) Moritz M. Gaidt et al. IMMUNITY
- Extracellular purines, purinergic receptors and tumor growth
- (2016) F Di Virgilio et al. ONCOGENE
- An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
- (2016) Ivan Zanoni et al. SCIENCE
- IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
- (2016) Rossana G. Iannitti et al. Nature Communications
- Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
- (2016) Chunhua Yang et al. Drug Design Development and Therapy
- Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation
- (2016) Ravichandran Panchanathan et al. Oncotarget
- IL-1 drives breast cancer growth and bone metastasis in vivo
- (2016) Ingunn Holen et al. Oncotarget
- Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
- (2016) Erica Salaro et al. Scientific Reports
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- The Q705K and F359L Single-Nucleotide Polymorphisms of NOD-Like Receptor Signaling Pathway: Association with Chronic Pancreatitis, Pancreatic Cancer, and Periodontitis
- (2015) Andrzej Miskiewicz et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis
- (2015) Josiah Ochieng et al. CARCINOGENESIS
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF- B Activation
- (2015) Z. Zhuang et al. CLINICAL CANCER RESEARCH
- The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice
- (2015) Sung-Hwa Sohn et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
- (2015) Robyn Marty-Roix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome
- (2015) Qing Wei et al. LABORATORY INVESTIGATION
- NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets
- (2015) Changyun Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)
- (2015) JOSÉ VERÍSSIMO FERNANDES et al. Oncology Letters
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Nucleotide signalling during inflammation
- (2014) Marco Idzko et al. NATURE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses
- (2014) Natalia Castaño-Rodríguez et al. PLoS One
- The Neutrophil NLRC4 Inflammasome Selectively Promotes IL-1β Maturation without Pyroptosis during Acute Salmonella Challenge
- (2014) Kaiwen W. Chen et al. Cell Reports
- Helicobacter pylori-induced gastric inflammation and gastric cancer
- (2013) Fei Wang et al. CANCER LETTERS
- IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells
- (2013) Shlomo Z. Ben-Sasson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
- (2013) Qing Wei et al. LABORATORY INVESTIGATION
- IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts
- (2013) M I Suwara et al. Mucosal Immunology
- Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway
- (2013) Xinshou Ouyang et al. Nature Communications
- Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
- (2013) Ryan W. Grant et al. Frontiers in Immunology
- The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines
- (2013) Busun Kim et al. Frontiers in Immunology
- Abstract 5461: Role of the NLRP3 inflammasome in the development and drug resistance of malignant mesothelioma
- (2012) Arti Shukla et al. CANCER RESEARCH
- Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
- (2012) Jonas Ungerbäck et al. CARCINOGENESIS
- NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma
- (2012) Melvyn T Chow et al. IMMUNOLOGY AND CELL BIOLOGY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
- (2012) Deepti Verma et al. Pigment Cell & Melanoma Research
- The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1β and IL-18 Production
- (2012) Deepti Verma et al. PLoS One
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- Mitochondrial ROS fuel the inflammasome
- (2011) Matthew T Sorbara et al. CELL RESEARCH
- The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. RHEUMATOLOGY
- Ultraviolet Radiation and Melanoma
- (2011) Holly E. Kanavy et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
- (2010) H. W. van Deventer et al. CANCER RESEARCH
- Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
- (2010) C. Bauer et al. GUT
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
- (2010) B. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
- (2009) Miyako Okamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women
- (2009) Nianfeng Qian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
- (2009) Luigi Franchi et al. NATURE IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of action of licensed vaccine adjuvants
- (2009) Elaine Tritto et al. VACCINE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now